Novartis Sues Cipla over COPD Drug Patents

Earlier this week Novartis launched a patent infringement lawsuit against Indian drugmaker Cipla for its October rollout of a COPD generic called Onbrez, which is known as Arcapta in the US. Last year, India's Supreme Court rejected Novartis' bid for a patent on its cancer drug Glivec, which opened the door for low-cost generics, and Novartis has been active in the fight over patents and pricing with Indian companies ever since.